Clariane SE (CLARI) - Total Assets

Latest as of December 2025: €13.81 Billion EUR ≈ $16.14 Billion USD

Based on the latest financial reports, Clariane SE (CLARI) holds total assets worth €13.81 Billion EUR (≈ $16.14 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Clariane SE book value and equity for net asset value and shareholders' equity analysis.

Clariane SE - Total Assets Trend (2004–2025)

This chart illustrates how Clariane SE's total assets have evolved over time, based on quarterly financial data.

Clariane SE - Asset Composition Analysis

Current Asset Composition (December 2025)

Clariane SE's total assets of €13.81 Billion consist of 12.3% current assets and 87.7% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 5.7%
Accounts Receivable €419.22 Million 3.0%
Inventory €36.23 Million 0.3%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €2.15 Billion 15.6%
Goodwill €3.13 Billion 22.7%

Asset Composition Trend (2004–2025)

This chart illustrates how Clariane SE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CLARI company net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Clariane SE's current assets represent 12.3% of total assets in 2025, an increase from 7.8% in 2004.
  • Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, up from 3.4% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 3.0% in 2004.
  • Asset Diversification: The largest asset category is goodwill at 22.7% of total assets.

Clariane SE Competitors by Total Assets

Key competitors of Clariane SE based on total assets are shown below.

Company Country Total Assets
Chemed Corp
NYSE:CHE
USA $1.62 Billion
Top Choice Medical Investment Co Inc
SHG:600763
China CN¥6.28 Billion
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Indonesia Rp8.99 Trillion
Oceania Healthcare Ltd
AU:OCA
Australia AU$3.01 Billion
Ramsay Health Care Ltd
AU:RHC
Australia AU$22.48 Billion
Regis Healthcare Ltd
AU:REG
Australia AU$2.11 Billion
Pacific Smiles Group Ltd
AU:PSQ
Australia AU$163.53 Million
Freedom Care Group Holdings Ltd
AU:FCG
Australia AU$9.86 Million

Clariane SE - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.70 0.56 0.72
Quick Ratio 0.69 0.56 0.71
Cash Ratio 0.00 0.02 0.00
Working Capital €-721.92 Million €-1.27 Billion €-731.52 Million

Clariane SE - Advanced Valuation Insights

This section examines the relationship between Clariane SE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.36
Latest Market Cap to Assets Ratio 0.10
Asset Growth Rate (YoY) -3.2%
Total Assets €13.81 Billion
Market Capitalization $1.34 Billion USD

Valuation Analysis

Below Book Valuation: The market values Clariane SE's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Clariane SE's assets decreased by 3.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Clariane SE (2004–2025)

The table below shows the annual total assets of Clariane SE from 2004 to 2025.

Year Total Assets Change
2025-12-31 €13.81 Billion
≈ $16.14 Billion
-3.18%
2024-12-31 €14.26 Billion
≈ $16.67 Billion
-6.06%
2023-12-31 €15.18 Billion
≈ $17.75 Billion
+4.17%
2022-12-31 €14.57 Billion
≈ $17.04 Billion
+1.86%
2021-12-31 €14.31 Billion
≈ $16.73 Billion
+8.42%
2020-12-31 €13.20 Billion
≈ $15.43 Billion
+20.65%
2019-12-31 €10.94 Billion
≈ $12.79 Billion
+43.48%
2018-12-31 €7.62 Billion
≈ $8.91 Billion
+7.15%
2017-12-31 €7.11 Billion
≈ $8.32 Billion
+9.56%
2016-12-31 €6.49 Billion
≈ $7.59 Billion
+12.65%
2015-12-31 €5.77 Billion
≈ $6.74 Billion
+9.71%
2014-12-31 €5.25 Billion
≈ $6.14 Billion
+126.83%
2013-12-31 €2.32 Billion
≈ $2.71 Billion
+3.80%
2012-12-31 €2.23 Billion
≈ $2.61 Billion
+6.84%
2011-12-31 €2.09 Billion
≈ $2.44 Billion
+10.24%
2010-12-31 €1.89 Billion
≈ $2.22 Billion
+4.01%
2009-12-31 €1.82 Billion
≈ $2.13 Billion
+5.25%
2008-12-31 €1.73 Billion
≈ $2.02 Billion
+2.94%
2007-12-31 €1.68 Billion
≈ $1.97 Billion
+34.58%
2006-12-31 €1.25 Billion
≈ $1.46 Billion
+6.54%
2005-12-31 €1.17 Billion
≈ $1.37 Billion
+114.36%
2004-12-31 €547.04 Million
≈ $639.55 Million
--

About Clariane SE

PA:CLARI France Medical Care Facilities
Market Cap
$1.68 Billion
€1.44 Billion EUR
Market Cap Rank
#7844 Global
#128 in France
Share Price
€4.04
Change (1 day)
+0.40%
52-Week Range
€3.32 - €5.36
All Time High
€24.48
About

Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care … Read more